Trials / Recruiting
RecruitingNCT06907771
Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian Cancer
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 130 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Ovarian cancer is the 8th leading cause of cancer-related death in women. Its prognosis is poor, with diagnosis often made at an advanced stage. Patient management has evolved in recent years with more radical surgeries and the introduction of maintenance treatment following neoadjuvant chemotherapy.
Conditions
Timeline
- Start date
- 2024-04-22
- Primary completion
- 2025-12-22
- Completion
- 2025-12-22
- First posted
- 2025-04-02
- Last updated
- 2025-04-02
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06907771. Inclusion in this directory is not an endorsement.